Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucentis vs Laser for Macular Edema in CRVO (BRAVO)
NCT01123564Phase 2Unknown
- Sponsor
- University of Pécs
- Start
- Aug 2009
- Primary completion
- Sep 2011
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in macular edema, central retinal vein occlusion (CRVO), sponsored by University of Pécs. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
macular edemacentral retinal vein occlusion (CRVO)
Beyond the preview
Go deeper on NCT01123564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01123564.